R. Cebe

First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis

I. Rozenberg, C. Calonder, F. D. Di Padova, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

“Redirecting an anti-IL-1β antibody to bind a new, unrelated and computationally predicted epitope on hIL-17A”

Guy Nimrod, Sharon Fischman, Michael Zhenin, 2023, Communications biology.